Presentation is loading. Please wait.

Presentation is loading. Please wait.

Stereotactic Body Radiation Therapy for Primary Lung Cancers >3 Centimeters  John J. Cuaron, MD, Ellen D. Yorke, PhD, Amanda Foster, BA, Meier Hsu, MS,

Published byAmando Castaldo Modified over 5 years ago

Similar presentations

Presentation on theme: "Stereotactic Body Radiation Therapy for Primary Lung Cancers >3 Centimeters  John J. Cuaron, MD, Ellen D. Yorke, PhD, Amanda Foster, BA, Meier Hsu, MS,"— Presentation transcript:

1 Stereotactic Body Radiation Therapy for Primary Lung Cancers >3 Centimeters 
John J. Cuaron, MD, Ellen D. Yorke, PhD, Amanda Foster, BA, Meier Hsu, MS, Zhigang Zhang, PhD, Fan Liu, PhD, Andrew Jackson, PhD, Borys Mychalczak, MD, Kenneth E. Rosenzweig, MD, Abraham J. Wu, MD, Andreas Rimner, MD  Journal of Thoracic Oncology  Volume 8, Issue 11, Pages (November 2013) DOI: /JTO.0b013e3182a47181 Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 An 85-year-old man with stage IIA non–small-cell lung cancer. The primary tumor was 5.5 cm in the greatest dimension as measured on a simulation computed tomography scan. The patient was treated with stereotactic body radiation therapy with 12 Gy × 4 fractions. The beam arrangement and isodose lines in the axial, sagittal, and coronal planes are shown above. ANT, anterior; SUP, superior. Journal of Thoracic Oncology 2013 8, DOI: ( /JTO.0b013e3182a47181) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Local failure-free survival by PTV. PTV, planning target volume. Journal of Thoracic Oncology 2013 8, DOI: ( /JTO.0b013e3182a47181) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

4 FIGURE 3 Time to chest wall pain by volume of chest wall receiving 30 Gy (V30). Journal of Thoracic Oncology 2013 8, DOI: ( /JTO.0b013e3182a47181) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "Stereotactic Body Radiation Therapy for Primary Lung Cancers >3 Centimeters  John J. Cuaron, MD, Ellen D. Yorke, PhD, Amanda Foster, BA, Meier Hsu, MS,"

Similar presentations

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages 1862-1863.

Massive Bronchogenic Cyst Joseph B. Levin, BA, Chi Wan Koo, MD, Jessica S. Donington, MD Journal of Thoracic Oncology Volume 5, Issue 11, Pages
Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated  Michael D. Chuong,

Stereotactic Body Radiation Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer Is Effective and Well Tolerated  Michael D. Chuong,
Jeffrey Bradley, MD  Journal of Thoracic Oncology 

Jeffrey Bradley, MD  Journal of Thoracic Oncology 
Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,

Size matters: A comparison of T1 and T2 peripheral non–small-cell lung cancers treated with stereotactic body radiation therapy (SBRT)  Neal E. Dunlap,
Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease  Eisaku.

Successful Osimertinib Rechallenge in a Patient with T790M-Mutant Non–Small Cell Lung Cancer after Osimertinib-Induced Interstitial Lung Disease  Eisaku.
Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD  Journal of Thoracic Oncology 

Chia-Lin Hsu, MD, Kuan-Yu Chen, MD, PhD  Journal of Thoracic Oncology 
Characteristics and outcomes of secondary nodules identified on initial computed tomography scan for patients undergoing resection for primary non–small.

Characteristics and outcomes of secondary nodules identified on initial computed tomography scan for patients undergoing resection for primary non–small.
One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 

One in every 14 patients with early-stage lung cancer is not being treated!  Benny Weksler, MD, MBA  The Journal of Thoracic and Cardiovascular Surgery 
Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis  Matthew Koshy, MD, Renuka Malik,

Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis  Matthew Koshy, MD, Renuka Malik,
Radiotherapeutic Management of Non–Small Cell Lung Cancer in the Minimal Resource Setting  Danielle Rodin, MD, Surbhi Grover, MD, MPH, Melody J. Xu, MD,

Radiotherapeutic Management of Non–Small Cell Lung Cancer in the Minimal Resource Setting  Danielle Rodin, MD, Surbhi Grover, MD, MPH, Melody J. Xu, MD,
Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D

Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D
Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization 

Severe Local Toxicity after Lung Stereotactic Body Radiation Therapy: Lesional Abscess Leading to Bronchocutaneous Fistula Requiring Surgical Marsupialization 
Postoperative Proton Therapy in the Management of Stage III Thymoma

Postoperative Proton Therapy in the Management of Stage III Thymoma
Andreas Rimner, MD, Daniel R. Gomez, MD, Abraham J

Andreas Rimner, MD, Daniel R. Gomez, MD, Abraham J
Radiotherapy Rescue of a Nivolumab-Refractory Immune Response in a Patient with PD-L1–Negative Metastatic Squamous Cell Carcinoma of the Lung  Zhigang.

Radiotherapy Rescue of a Nivolumab-Refractory Immune Response in a Patient with PD-L1–Negative Metastatic Squamous Cell Carcinoma of the Lung  Zhigang.
Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree  Justin M. Haseltine, BSE,

Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree  Justin M. Haseltine, BSE,
Prognostic Value of Primary Tumor Volume Changes on kV-CBCT during Definitive Chemoradiotherapy for Stage III Non–Small Cell Lung Cancer  Patrick Wald,

Prognostic Value of Primary Tumor Volume Changes on kV-CBCT during Definitive Chemoradiotherapy for Stage III Non–Small Cell Lung Cancer  Patrick Wald,
Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD 
Intensity-Modulated Radiotherapy for Lung Cancer: Current Status and Future Developments  Clara Chan, MD, Stephanie Lang, MSc, Carl Rowbottom, PhD, Matthias.

Intensity-Modulated Radiotherapy for Lung Cancer: Current Status and Future Developments  Clara Chan, MD, Stephanie Lang, MSc, Carl Rowbottom, PhD, Matthias.
Use of Stereotactic Ablative Radiotherapy (SABR) in Non–Small Cell Lung Cancer Measuring More Than 5 cm  Hilâl Tekatli, MD, Saar van ’t Hof, MD, Esther.

Use of Stereotactic Ablative Radiotherapy (SABR) in Non–Small Cell Lung Cancer Measuring More Than 5 cm  Hilâl Tekatli, MD, Saar van ’t Hof, MD, Esther.

Similar presentations

Ads by Google